Workflow
7月16日晚间公告 | 邮储银行拟出资100亿元设立子公司;拓新药业拟对麦角硫因品类龙头增资
Xuan Gu Bao·2025-07-16 12:00

Group 1: Capital Increase - Fengshen Co., Ltd. plans to raise no more than 1.1 billion yuan for the high-performance giant engineering radial tire expansion project [1] - Shangwei Co., Ltd. intends to raise no more than 1.14 billion yuan for digital upgrade and comprehensive capability enhancement projects, marketing center and brand promotion projects, and to supplement working capital [1] Group 2: Share Transfer and Buyback - Huayuan Holdings plans to repurchase shares for an amount between 20 million to 40 million yuan, with a repurchase price not exceeding 28 yuan per share [2] - Hesheng Silicon Industry's controlling shareholder is transferring 5.08% of the company's shares at a price of 43.9 yuan per share [3] Group 3: External Investment and Daily Operations - Tuoxin Pharmaceutical plans to increase its investment in Jingsan Biotechnology by 10 million yuan, acquiring a 1.75% stake, as Jingsan Biotechnology has achieved high-purity ergotamine production [4] - Medike intends to acquire 100% equity of Haishuo Optical Technology and INNOWAVE VIETNAM CO., LTD. for a total transaction amount of 2.1947 million USD [4] - Postal Savings Bank plans to invest 10 billion yuan to establish China Post Financial Asset Investment Co., Ltd. [4] - Wuchan Zhongda intends to acquire 100% equity of Huzhou South Taihu Power Technology Co., Ltd. for 1.457 billion yuan [4] - Shanghai Kaibao plans to opportunistically sell part of its stake in Shanghai Yizhong Pharmaceutical Co., Ltd., not exceeding 6.2011 million shares [4] - Weikang Pharmaceutical has received a notice of acceptance for the listing application of Vitamin K1 injection [4] - Jindi Co., Ltd. signed an industrial project investment contract with the People's Government of Chongqing Banan District to build a high-end equipment key component intelligent manufacturing project, with a total investment of no less than 1.5 billion yuan [4] - CanSino has received approval for clinical trials of its trivalent poliovirus vaccine (Sf-RVN cells) [4] - Heng'erda has established a strategic cooperation relationship with Tiangong International for joint research and development, manufacturing, industrial application, and joint external investment in areas such as powder metal materials and precision cutting tools [4] - Anker Innovation is currently conducting research and analysis on equity financing in the Hong Kong capital market [4] - Tianci Materials' wholly-owned subsidiary Jiujiang Tianci signed a procurement cooperation agreement with Chuangneng New Energy, with an expected supply of no less than 550,000 tons of electrolyte series products [5] Group 4: Performance Changes - Pinming Technology expects a net profit of 28 million to 34 million yuan for the first half of 2025, representing a year-on-year increase of 232% to 303%, with revenue from its building information software business increasing and its revenue proportion rising [6]